Treatment of perinatal viral infections to improve neurologic outcomes.
Viral infections in the fetus or newborn often involve the central nervous system (CNS) and can lead to significant morbidity and mortality. Substantial progress has been made in identifying interventions decreasing adverse neurodevelopmental outcomes in this population. This review highlights progress in treatment of important viruses affecting the CNS in these susceptible hosts, focusing on herpes simplex virus (HSV), cytomegalovirus (CMV), human immunodeficiency virus (HIV), and enteroviruses. The observation that high-dose acyclovir improves mortality in neonatal HSV disease culminated decades of antiviral research for this disease. More recently, prolonged oral acyclovir was found to improve neurologic morbidity after neonatal HSV encephalitis. Ganciclovir, and more recently its oral prodrug valganciclovir, is effective in improving hearing and neurodevelopment after congenital CMV infection. Increasing evidence suggests early control of perinatal HIV infection has implications for neurocognitive functioning into school age. Lastly, the antiviral pleconaril has been studied for nearly two decades for treating severe enteroviral infections, with newer data supporting a role for this drug in neonates. Identifying common mechanisms for pathogenesis of viral CNS disease during this critical period of brain development is an important research goal, highlighted by the recent emergence of Zika virus as a potential cause of fetal neurodevelopmental abnormalities.
Department of Pediatrics, Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
William J
WJ
Muller
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D003071:Cognition; D003072:Cognition Disorders / Q000150:complications; D020803:Encephalitis, Herpes Simplex / Q000150:complications; D004769:Enterovirus Infections / Q000150:complications; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D015658:HIV Infections / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D009422:Nervous System Diseases / Q000150:complications* / Q000517:prevention & control; D010069:Oxadiazoles / Q000627:therapeutic use; D010080:Oxazoles; D011247:Pregnancy; D000077562:Valganciclovir; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D010069:Oxadiazoles; D010080:Oxazoles; C115201:pleconaril; D000077562:Valganciclovir; D015774:Ganciclovir; D000212:Acyclovir
Trop Med Int Health. 2004 Jun;9(6):730-6
15189465
Infect Dis Clin North Am. 2015 Dec;29(4):651-65
26610419
J Infect Dis. 1994 Nov;170(5):1267-71
7963724
JAMA Pediatr. 2014 Feb;168(2):148-55
24311021
J Pediatric Infect Dis Soc. 2016 Mar;5(1):63-4
26407264
Lab Invest. 2014 Feb;94(2):161-81
24378643
N Engl J Med. 2001 May 3;344(18):1366-71
11333993
J Antimicrob Chemother. 1984 Aug;14 Suppl A:57-74
6092319
Lancet. 2012 Feb 4;379(9814):445-52
22244654
Pediatr Infect Dis J. 2003 Apr;22(4):371-2
12690281
N Engl J Med. 2011 Oct 6;365(14):1284-92
21991950
Pediatr Infect Dis J. 1993 Oct;12(10):820-4
8284118
Nature. 2013 Feb 14;494(7436):201-6
23364696
Pediatr Infect Dis J. 2012 Jun;31(6):592-8
22592486
J Virol. 1989 May;63(5):2002-7
2539499
J Pediatr. 1970 Aug;77(2):315-33
4194002
Pediatrics. 2008 Nov;122(5):1127-34
18977995
PLoS Med. 2012 Jan;9(1):e1001158
22272190
Cell Stem Cell. 2016 May 5;18(5):591-6
27038591
Vaccine. 2013 Apr 18;31 Suppl 2:B197-203
23598482
J Virol. 2009 Sep;83(18):9356-69
19570873
Rev Obstet Gynecol. 2010 Fall;3(4):172-9
21364849
Clin Pharmacol Ther. 1993 Jan;53(1):15-21
8380762
MMWR Morb Mortal Wkly Rep. 2015 Sep 04;64(34):940-3
26334674
J Infect Dis. 1980 Jun;141(6):712-5
6248601
AIDS. 2012 Aug 24;26(13):1685-90
22614886
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34
23760231
Arch Ophthalmol. 1962 Aug;68:235-9
14454436
J Infect Dis. 2014 Nov 1;210 Suppl 1:S5-15
25316873
Pediatr Infect Dis J. 2000 Sep;19(9):833-9
11001105
J Virol. 2013 Jan;87(1):474-81
23097453
J Clin Virol. 2009 Dec;46 Suppl 4:S22-6
19766534
Antimicrob Agents Chemother. 1999 Sep;43(9):2109-15
10471549
Antimicrob Agents Chemother. 1996 Sep;40(9):2202-5
8878608
Nature. 2015 Nov 19;527(7578):S151-4
26580320
Pediatr Infect Dis J. 2008 Jun;27(6):500-4
18434933
Pediatr Infect Dis J. 2010 Mar;29(3):199-204
19949362
Am J Ophthalmol. 2003 Oct;136(4):733-5
14516816
Lancet Infect Dis. 2015 Jun;15(6):671-82
25837569
Pediatrics. 2001 Aug;108(2):230-8
11483782
PLoS Pathog. 2015 Apr 13;11(4):e1004774
25875183
Clin Infect Dis. 1997 Dec;25(6):1374-7
9431381
J Virol. 2002 Sep;76(17):8842-54
12163604
Rev Med Virol. 2014 Sep;24(5):316-31
24806816
Pediatrics. 2005 Mar;115(3):804-9
15741392
Clin Infect Dis. 2001 Jan 15;32(2):228-35
11170912
AIDS. 2005 Apr 29;19(7):675-84
15821393
J Infect Dis. 1997 May;175(5):1080-6
9129069
N Engl J Med. 2007 Mar 22;356(12):1226-34
17377160
Am J Pathol. 1935 Jan;11(1):127-142.5
19970188
J Neurovirol. 1999 Dec;5(6):670-7
10602407
Am J Pathol. 2003 Oct;163(4):1379-93
14507646
J Virol. 2013 Nov;87(22):12407-21
24027313
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 3:S490-4
2847285
Nature. 2015 Nov 19;527(7578):S178-86
26580325
Acta Paediatr. 2012 Feb;101(2):120-7
22003882
N Engl J Med. 2015 Mar 5;372(10 ):933-43
25738669
Indian J Med Res. 1985 Jan;81:9-12
2985501
N Engl J Med. 1991 Feb 14;324(7):444-9
1988829
Pediatrics. 1992 Dec;90(6):862-6
1331946
MBio. 2016 Apr 12;7(2):e00437-16
27073094
J Virol. 2008 Dec;82(24):12172-80
18842707
Pediatr Clin North Am. 2013 Apr;60(2):335-49
23481104
Am J Dis Child. 1990 Dec;144(12):1365-8
2173889
N Engl J Med. 2016 May 19;374(20):1981-7
27074377
Nature. 2015 Nov 19;527(7578):S167-71
26580323
Am J Epidemiol. 2010 Dec 1;172(11):1213-29
20978089
Scand J Infect Dis. 2009;41(11-12):898-9
19922078
Pediatrics. 2006 Mar;117(3):851-62
16510667
Nestle Nutr Workshop Ser Pediatr Program. 2008;61:183-95
18196952
J Acquir Immune Defic Syndr. 2010 Sep;55(1):134-6
20733406
Bacteriol Rev. 1964 Dec;28:458-71
14244724
J Ment Defic Res. 1979 Mar;23(1):63-8
480342
J Acquir Immune Defic Syndr. 2009 Dec;52(5):636-42
19730268
Pediatr Res. 2014 Dec;76(6):528-34
25198371
Bull Soc Pathol Exot. 1991;84(5 Pt 5):513-21
1819401
J Infect Dis. 2008 Mar 15;197(6):836-45
18279073
J Pediatr. 2015 Apr;166(4):827-33
25491092
J Child Neurol. 2008 Sep;23(9):1028-35
18287573
Pediatr Infect Dis J. 2009 Oct;28(10):904-10
20118685
Pediatrics. 1980 Oct;66(4):495-501
7001331
J Pediatric Infect Dis Soc. 2016 Mar;5(1):53-62
26407253
Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):488-93
11944704
Lancet Infect Dis. 2014 Aug;14(8):751-62
24877996
N Engl J Med. 1999 Sep 23;341(13):936-42
10498488
PLoS Pathog. 2015 Jan 08;11(1):e1004580
25569138
J Pediatr. 2003 Jul;143(1):16-25
12915819
J Antimicrob Chemother. 2009 May;63(5):862-7
19287011
Pediatrics. 2005 Mar;115(3):795-7
15741389
Euro Surveill. 2015 Mar 12;20(10):21062
25788251
Lancet. 2015 Apr 25;385(9978):1662-71
25638662
Nat Rev Immunol. 2007 May;7(5):379-90
17457344
Pediatr Infect Dis J. 2003 Apr;22(4):335-41
12690273
Lab Invest. 2002 Oct;82(10):1347-58
12379769
AIDS. 2015 Jan 28;29(3):295-304
25686678
Pediatrics. 1980 Nov;66(5):758-62
6159568
Pediatrics. 1983 Dec;72(6):778-85
6359047
Reprod Toxicol. 2006 May;21(4):350-82
16564672
Pediatr Infect Dis J. 1992 Feb;11(2):93-9
1311066